Abstract
The aim of this study was to ascertain the practice of urologists in Scotland in the assessment and prevention of fracture risk in males starting castration-type therapy for prostate cancer. A questionnaire survey was sent to all practicing consultant urologists in Scotland. A majority of urologists, 25 (64.1%), did not consider the state of their patients' bone mineral density (BMD) before commencing castration-type therapy. The rest used various methods to assess BMD, including clinical impression alone, plain bone radiographs, and dual-energy X-ray absorptiometry (DEXA). Various methods were used in the prophylaxis and treatment of osteoporosis, including avoidance of castration type therapy and the use of bisphosphonates and bicalutamide along with castration-type therapy. This study has shown that there is no consensus as to the assessment and management of fracture risk in patients with prostate cancer commencing or on established castration-type therapy. The situation needs to be addressed with some consensus guidance.
| Original language | English |
|---|---|
| Pages (from-to) | 1590-1595 |
| Number of pages | 6 |
| Journal | Scientific World Journal |
| Volume | 7 |
| DOIs | |
| Publication status | Published - 2007 |
Keywords
- Age Distribution
- Comorbidity
- Fractures, Bone
- Health Services for the Aged
- Humans
- Male
- Physician's Practice Patterns
- Prevalence
- Prostatic Neoplasms
- Questionnaires
- Risk Assessment
- Risk Factors
- Urology
